3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
8
Breast Neoplasms
8
Vitamin D Deficiency
7
Polycystic Ovary Syndrome
4
Leukemia, Lymphocytic, Chronic, B-Cell
3
Warts
2
Rectal Neoplasms
2
Osteoporosis
2
Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Stroke
1
Spinal Cord Injuries
1
Seizures
1
Psoriasis
1
Prostate Adenocarcinoma
1
Polyps
1
Pathologic Processes
1
Pain
1
Ovarian Neoplasms
1
Osteoarthritis
1
Obesity
1
Neoplasms by Site
1
Myelodysplastic Syndromes
1
Meningitis
1
Melanoma, Cutaneous Malignant
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Interventions
Methotrexate
8
Adalimumab
7
Etanercept
5
tocilizumab
4
Rituximab
4
tofacitinib
3
Abatacept
3
olokizumab
2
golimumab
2
Tumor Necrosis Factor Inhibitors
2
Antirheumatic Agents
2
upadacitinib
1
secukinumab
1
sarilumab
1
mavrilimumab
1
baricitinib
1
andecaliximab
1
Vitamin D
1
Vaccines
1
TACI receptor-IgG Fc fragment fusion protein
1
Syringes
1
Sulfasalazine
1
Saline Solution
1
Leflunomide
1
Hydroxychloroquine
1
Herpes Zoster Vaccine
1
Folic Acid
1
Fish Oils
1
Fatty Acids, Omega-3
1
Eicosapentaenoic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Arthritis, Rheumatoid
×
Cholecalciferol
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts